InvestorsHub Logo
Followers 0
Posts 48
Boards Moderated 0
Alias Born 09/30/2017

Re: None

Saturday, 04/27/2019 12:20:02 PM

Saturday, April 27, 2019 12:20:02 PM

Post# of 3063
It has been overlooked that Anthony Suave in his new study declares NRH to be a "potent pharma agent that is 2.5 to 10 times
more potent than NR in raising NAD+ levels".
CDXC obtained a GRANTED patent covering NRH on 1-22-19 that will further the possibility of a pharma partner/buyout.
Scroll way down on the patent link to see a table comparing the potency of NRH to NR.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDXC News